These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 4730978

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
    Sriyabhaya N, Jarumilin A.
    J Med Assoc Thai; 1972 Apr; 55(4):235-7. PubMed ID: 5022496
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
    Ige OM, Bakare NA, Onadeko BO.
    Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
    [Abstract] [Full Text] [Related]

  • 8. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S.
    Rev Clin Esp; 1972 May 31; 125(4):353-6. PubMed ID: 5080180
    [No Abstract] [Full Text] [Related]

  • 9. Short-course treatment in pulmonary tuberculosis.
    East Afr Med J; 1973 Dec 31; 50(12):672-80. PubMed ID: 4132127
    [No Abstract] [Full Text] [Related]

  • 10. [Late results of treatment of chronic pulmonary tuberculosis with rifampicin].
    Lachowicz E, Polaczek E, Araszkiewicz W, Kozakow H, Pszonicka A, Styszewska H, Janowiec M, Grabowska R.
    Gruzlica; 1973 Jul 31; 41(7):781-7. PubMed ID: 4730979
    [No Abstract] [Full Text] [Related]

  • 11. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
    Chan SL, Yew WW, Ma WK, Girling DJ, Aber VR, Felmingham D, Allen BW, Mitchison DA.
    Tuber Lung Dis; 1992 Feb 31; 73(1):33-8. PubMed ID: 1326348
    [Abstract] [Full Text] [Related]

  • 12. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
    Harries AD, Gausi F, Chimzizi R, Salaniponi FM.
    Int J Tuberc Lung Dis; 2004 Mar 31; 8(3):384-7. PubMed ID: 15139479
    [Abstract] [Full Text] [Related]

  • 13. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM, Chan SL, Kam KM, Goodall RL, Mitchison DA.
    Int J Tuberc Lung Dis; 2002 Jan 31; 6(1):3-10. PubMed ID: 11931398
    [Abstract] [Full Text] [Related]

  • 14. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A, Gogate A.
    Indian J Public Health; 1998 Jan 31; 42(4):126-30. PubMed ID: 10389525
    [Abstract] [Full Text] [Related]

  • 15. [Short-term treatment of pulmonary tuberculosis].
    Karuga WK.
    Bull Int Union Tuberc; 1974 Jan 31; 49(1):388-97. PubMed ID: 4143178
    [No Abstract] [Full Text] [Related]

  • 16. Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.
    Sundaram V, Fujiwara PI, Driver CR, Osahan SS, Munsiff SS.
    Int J Tuberc Lung Dis; 2002 Mar 31; 6(3):238-45. PubMed ID: 11934142
    [Abstract] [Full Text] [Related]

  • 17. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML, Iuditskiĭ MV, Semenova OV.
    Probl Tuberk Bolezn Legk; 2004 Mar 31; (3):26-8. PubMed ID: 15338896
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK, Rajpal S, Bhalla P, Yadav A, Jain SK, Hanif M.
    J Commun Dis; 2003 Jun 31; 35(2):82-9. PubMed ID: 15562953
    [Abstract] [Full Text] [Related]

  • 19. Comparative controlled trial of rimactane in pulmonary tuberculosis.
    Dormer BA.
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr 31; 2(2):188. PubMed ID: 4895449
    [No Abstract] [Full Text] [Related]

  • 20. [Late results of treatment with rifampicin combined with SM and INH in newly detected cases of pulmonary tuberculosis].
    Szymański A.
    Pneumonol Pol; 1976 Mar 31; 44(3):227-35. PubMed ID: 1257096
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.